US 12109196
Non-sedating dexmedetomidine treatment regimens
granted A61KA61K31/4174A61K47/10
Quick answer
US patent 12109196 (Non-sedating dexmedetomidine treatment regimens) held by BioXcel Therapeutics, Inc. expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioXcel Therapeutics, Inc.
- Grant date
- Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/4174, A61K47/10, A61K47/26, A61K47/34